In the planned study patients with painful epicondylitis humeroradialis of the ellbow are treated with leeches or a standard treatment.
Conditions
Interventions
Trade Name: natural leech
Product Name: leech (Hirudo medicinalis), lively
Pharmaceutical Form:
Trade Name: Voltaren Emulgel
Pharmaceutical Form:
Sponsors
Prof. Gustav Dobos, Kliniken Essen Mitte
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Diagnosis of Epicondylitis - pain on more than 50% of the days in the last month - age 20-75 years old - informed consent - no planned treatment or operation within the next 3 month Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: - other causes of ellbow pain than epicondylitis humeroradialis - steroid injection within the last 3 weeks - hemophilia or othe bleeding disorders - medication with marumar, warfarin, heparin or heparinoids - anemia - renal failure - severe other comorbidity - pregnancy - psychosis - dementia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Background: Leeches therapy has been proven to be successful in the treatment of knee osteoarthritis. Its effects in epicondylitis is unknown. Main objective: To evaluate the symptomatic effects of a single leech therapy versus topical adminstration of diclofenac at epicondylitis humeroradialis. Main outomce parameter is assessed by Visual Analogue scale for pain at one week after the intervention.;Secondary Objective: To assess the improvement of Joint function (DASH-Questionaire), related qualitiy of life (SF 36) and isometric strength of the hand extensors.;Primary end point(s): Pain reduction on self rated VAS sum-score at day 7 after the intervetion compared to baseline. | — |
Countries
Germany
Outcome results
None listed